Oxford Immunotec to Present at the 28th Annual Piper Jaffray Healthcare Conference
OXFORD, United Kingdom and MARLBOROUGH, Mass., 2016-11-17 15:15 CET (GLOBE NEWSWIRE) --
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the 28thAnnual Piper Jaffray Healthcare Conference on Wednesday, November 30th, at 10:30 a.m. EST at the Lotte New York Palace.
Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions. The Company’s first product is the TSPOT®.TBtest, which is used to test for tuberculosis infection. The T-SPOT.TBtest has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The company’s second product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. The T-SPOT.CMVtest and the T-SPOT.PRTtest are part of the Company’s third product line focused on the transplantation market. In addition to these three product lines, the Company has additional active development programs in other immune-regulated conditions. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass. Additional information can be found atwww.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd. Immunetics is a trademark of Immunetics, Inc.
For Media Inquiries:
Tel: +44 1235 442796
For Investor Inquiries:
Chief Financial Officer
Tel: +1 (508) 573-9953
Tel: +1 (443) 213-0501
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
JD Norman Industries, Inc.18.1.2018 06:02 | pressemeddelelse
JD Norman Industries, Inc. Completes Acquisition of REGE Motorenteile
Aptean17.1.2018 21:01 | pressemeddelelse
Partnership With FAST Technologies Expands Aptean's European Footprint
World Finance17.1.2018 15:30 | pressemeddelelse
Egyptian Steel recognised in the World Finance 100 guide for 2017
European CEO17.1.2018 15:07 | pressemeddelelse
Investing in Berlin's thriving real estate market
Crown Bioscience Inc.17.1.2018 14:14 | pressemeddelelse
Innovative Humanized Research Strategies for Immuno-Oncology Drug Development, Crown Bioscience Hosts a Live Webinar
Colliers International Group Inc.17.1.2018 13:33 | pressemeddelelse
Colliers Launches Real Estate Technology Accelerator With Techstars
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum